These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 36982210)

  • 21. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
    Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
    Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis.
    You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y
    Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer.
    Ebrahimi S; Hosseini M; Ghasemi F; Shahidsales S; Maftouh M; Akbarzade H; Parizadeh SA; Hassanian SM; Avan A
    Curr Pharm Des; 2016; 22(42):6444-6450. PubMed ID: 27539232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of selected microRNAs in pancreatic ductal adenocarcinoma: is there a relation to tumor morphology, progression and patient's outcome?
    Szabo A; Gurlich R; Liberko M; Soumarova R; Vernerova Z; Mandys V; Popov A
    Neoplasma; 2020 Sep; 67(5):1170-1181. PubMed ID: 32567937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Network-Based Approach for Identification of Subtype-Specific Master Regulators in Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Zhu L; Wang X
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32024063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.
    Stroese AJ; Ullerich H; Koehler G; Raetzel V; Senninger N; Dhayat SA
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2377-2390. PubMed ID: 30225540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
    Carlsen AL; Joergensen MT; Knudsen S; de Muckadell OB; Heegaard NH
    Pancreas; 2013 Oct; 42(7):1107-13. PubMed ID: 24048453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
    Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
    Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
    Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer.
    Watanabe F; Suzuki K; Noda H; Rikiyama T
    World J Gastroenterol; 2022 Dec; 28(46):6478-6496. PubMed ID: 36569270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study.
    Makler A; Asghar W
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
    Steele CW; Oien KA; McKay CJ; Jamieson NB
    Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients.
    Kawamura S; Iinuma H; Wada K; Takahashi K; Minezaki S; Kainuma M; Shibuya M; Miura F; Sano K
    J Hepatobiliary Pancreat Sci; 2019 Feb; 26(2):63-72. PubMed ID: 30561106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis.
    Hu GY; Tao F; Wang W; Ji KW
    World J Surg Oncol; 2016 Mar; 14():82. PubMed ID: 26969625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma.
    Gao Z; Jiang W; Zhang S; Li P
    Anal Cell Pathol (Amst); 2019; 2019():9419072. PubMed ID: 31583198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.